Cargando…

CisPi: a transcriptomic score for disclosing cis-acting disease-associated lincRNAs

MOTIVATION: Long intergenic noncoding RNAs (lincRNAs) have risen to prominence in cancer biology as new biomarkers of disease. Those lincRNAs transcribed from active cis-regulatory elements (enhancers) have provided mechanistic insight into cis-acting regulation; however, in the absence of an enhanc...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zhezhen, Cunningham, John M, Yang, Xinan H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6129262/
https://www.ncbi.nlm.nih.gov/pubmed/30423099
http://dx.doi.org/10.1093/bioinformatics/bty574
_version_ 1783353770021748736
author Wang, Zhezhen
Cunningham, John M
Yang, Xinan H
author_facet Wang, Zhezhen
Cunningham, John M
Yang, Xinan H
author_sort Wang, Zhezhen
collection PubMed
description MOTIVATION: Long intergenic noncoding RNAs (lincRNAs) have risen to prominence in cancer biology as new biomarkers of disease. Those lincRNAs transcribed from active cis-regulatory elements (enhancers) have provided mechanistic insight into cis-acting regulation; however, in the absence of an enhancer hallmark, computational prediction of cis-acting transcription of lincRNAs remains challenging. Here, we introduce a novel transcriptomic method: a cis-regulatory lincRNA–gene associating metric, termed ‘CisPi’. CisPi quantifies the mutual information between lincRNAs and local gene expression regarding their response to perturbation, such as disease risk-dependence. To predict risk-dependent lincRNAs in neuroblastoma, an aggressive pediatric cancer, we advance this scoring scheme to measure lincRNAs that represent the minority of reads in RNA-Seq libraries by a novel side-by-side analytical pipeline. RESULTS: Altered expression of lincRNAs that stratifies tumor risk is an informative readout of oncogenic enhancer activity. Our CisPi metric therefore provides a powerful computational model to identify enhancer-templated RNAs (eRNAs), eRNA-like lincRNAs, or active enhancers that regulate the expression of local genes. First, risk-dependent lincRNAs revealed active enhancers, over-represented neuroblastoma susceptibility loci, and uncovered novel clinical biomarkers. Second, the prioritized lincRNAs were significantly prognostic. Third, the predicted target genes further inherited the prognostic significance of these lincRNAs. In sum, RNA-Seq alone is sufficient to identify disease-associated lincRNAs using our methodologies, allowing broader applications to contexts in which enhancer hallmarks are not available or show limited sensitivity. AVAILABILITY AND IMPLEMENTATION: The source code is available on request. The prioritized lincRNAs and their target genes are in the Supplementary Material. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.
format Online
Article
Text
id pubmed-6129262
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-61292622018-09-12 CisPi: a transcriptomic score for disclosing cis-acting disease-associated lincRNAs Wang, Zhezhen Cunningham, John M Yang, Xinan H Bioinformatics Eccb 2018: European Conference on Computational Biology Proceedings MOTIVATION: Long intergenic noncoding RNAs (lincRNAs) have risen to prominence in cancer biology as new biomarkers of disease. Those lincRNAs transcribed from active cis-regulatory elements (enhancers) have provided mechanistic insight into cis-acting regulation; however, in the absence of an enhancer hallmark, computational prediction of cis-acting transcription of lincRNAs remains challenging. Here, we introduce a novel transcriptomic method: a cis-regulatory lincRNA–gene associating metric, termed ‘CisPi’. CisPi quantifies the mutual information between lincRNAs and local gene expression regarding their response to perturbation, such as disease risk-dependence. To predict risk-dependent lincRNAs in neuroblastoma, an aggressive pediatric cancer, we advance this scoring scheme to measure lincRNAs that represent the minority of reads in RNA-Seq libraries by a novel side-by-side analytical pipeline. RESULTS: Altered expression of lincRNAs that stratifies tumor risk is an informative readout of oncogenic enhancer activity. Our CisPi metric therefore provides a powerful computational model to identify enhancer-templated RNAs (eRNAs), eRNA-like lincRNAs, or active enhancers that regulate the expression of local genes. First, risk-dependent lincRNAs revealed active enhancers, over-represented neuroblastoma susceptibility loci, and uncovered novel clinical biomarkers. Second, the prioritized lincRNAs were significantly prognostic. Third, the predicted target genes further inherited the prognostic significance of these lincRNAs. In sum, RNA-Seq alone is sufficient to identify disease-associated lincRNAs using our methodologies, allowing broader applications to contexts in which enhancer hallmarks are not available or show limited sensitivity. AVAILABILITY AND IMPLEMENTATION: The source code is available on request. The prioritized lincRNAs and their target genes are in the Supplementary Material. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online. Oxford University Press 2018-09-01 2018-09-08 /pmc/articles/PMC6129262/ /pubmed/30423099 http://dx.doi.org/10.1093/bioinformatics/bty574 Text en © The Author(s) 2018. Published by Oxford University Press. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Eccb 2018: European Conference on Computational Biology Proceedings
Wang, Zhezhen
Cunningham, John M
Yang, Xinan H
CisPi: a transcriptomic score for disclosing cis-acting disease-associated lincRNAs
title CisPi: a transcriptomic score for disclosing cis-acting disease-associated lincRNAs
title_full CisPi: a transcriptomic score for disclosing cis-acting disease-associated lincRNAs
title_fullStr CisPi: a transcriptomic score for disclosing cis-acting disease-associated lincRNAs
title_full_unstemmed CisPi: a transcriptomic score for disclosing cis-acting disease-associated lincRNAs
title_short CisPi: a transcriptomic score for disclosing cis-acting disease-associated lincRNAs
title_sort cispi: a transcriptomic score for disclosing cis-acting disease-associated lincrnas
topic Eccb 2018: European Conference on Computational Biology Proceedings
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6129262/
https://www.ncbi.nlm.nih.gov/pubmed/30423099
http://dx.doi.org/10.1093/bioinformatics/bty574
work_keys_str_mv AT wangzhezhen cispiatranscriptomicscorefordisclosingcisactingdiseaseassociatedlincrnas
AT cunninghamjohnm cispiatranscriptomicscorefordisclosingcisactingdiseaseassociatedlincrnas
AT yangxinanh cispiatranscriptomicscorefordisclosingcisactingdiseaseassociatedlincrnas